Rafael Holdings Inc (NYSE:RFL)

4.97
Delayed Data
As of Jan 14
 +0.06 / +1.22%
Today’s Change
4.50
Today|||52-Week Range
66.44
-2.55%
Year-to-Date
SECTOR
Finance
INDUSTRY
Real Estate Development
MARKET CAP
$98.9M

Company Description

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. It operates through the Real Estate and Pharmaceuticals segments. The Real Estate segment refers to the real estate holdings. The Pharmaceuticals segment is comprised of debt interests and warrants in Rafael Pharmaceuticals and a majority equity interest in LipoMedix Pharmaceuticals. The company was founded in 2017 and is headquartered in Newark, NJ.

Contact Information

Rafael Holdings, Inc.
520 Broad Street
Newark New Jersey 07102
P:(212) 658-1450
Investor Relations:
(203) 274-2825

Employees

Shareholders

Other institutional31.51%
Individual stakeholders14.25%
Mutual fund holders12.69%

Top Executives

Ameet MallikChief Executive Officer & Director
Patrick FabbioPresident & Chief Financial Officer
Gus KodershaChief Technical Operations Officer
Mary Margaret HuizingaChief Medical Officer, Head-Research & Development
Melissa LoznerChief Compliance & Ethics Officer